NCT06252714

Brief Summary

The study aims to determine if defecation posture, when using a defecation posture modification device (DPMD), will improve ease of bowel movements in patients with pelvic organ prolapse, specifically rectoceles.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
60

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Mar 2024

Geographic Reach
1 country

3 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

February 2, 2024

Completed
10 days until next milestone

First Posted

Study publicly available on registry

February 12, 2024

Completed
18 days until next milestone

Study Start

First participant enrolled

March 1, 2024

Completed
1.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2025

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

October 1, 2025

Completed
Last Updated

January 29, 2026

Status Verified

January 1, 2026

Enrollment Period

1.5 years

First QC Date

February 2, 2024

Last Update Submit

January 28, 2026

Conditions

Keywords

defecation posture modification devicedefecation posture

Outcome Measures

Primary Outcomes (1)

  • Straining with bowel movements

    Patients will assess straining with bowel movement on a 0 -10 numeric scale. The scale is called straining or ease with bowel movements. The number 0 indicates no straining and the number 10 indicates maximal straining with bowel movement.

    2 weeks

Secondary Outcomes (4)

  • Colorectal-Anal Distress Inventory 8

    2 weeks

  • Consistency of stool

    2 weeks

  • Use of laxative medication

    2 weeks

  • Ease of device use

    2 weeks

Study Arms (1)

Defecation Posture Modification Device

EXPERIMENTAL

Patients will be given a Squatty Potty Device

Device: Defecation Posture Modification Device

Interventions

Patients will be asked to use the defecation posture modification device with each bowel movement for two weeks.

Also known as: Squatty potty
Defecation Posture Modification Device

Eligibility Criteria

Age18 Years+
Sexfemale(Gender-based eligibility)
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients with pelvic organ prolapse, including a rectocele (posterior compartment measurements to Stage 2 or greater) that endorse bowel dysfunction, based on our office standard screening questionnaires

You may not qualify if:

  • Anyone currently using a defecation posture modification device Unwillingness or unable to participate in the study Planned travel, inability to use device during the study period Patient preparing to undergo pelvic reconstructive surgery prior to the end of the study period Presence of ileostomy/colostomy Bowel disease such as Crohn's disease or Ulcerative Colitis Daily opiate use Wheelchair bound If device may pose fall or safety hazard risk to patient, such as need for walker or cane for ambulation.
  • Patients weighing over 250 lbs, per manufacturer guidelines for the device Inability to understand English Pregnant women

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (3)

Cincinnati Urogynecology Associates

Cincinnati, Ohio, 45220, United States

Location

Good Samaritan Hospital

Cincinnati, Ohio, 45220, United States

Location

Bethesda North Hospital

Cincinnati, Ohio, 45242, United States

Location

MeSH Terms

Conditions

Pelvic Organ ProlapseRectoceleIntestinal Diseases

Condition Hierarchy (Ancestors)

ProlapsePathological Conditions, AnatomicalPathological Conditions, Signs and SymptomsRectal DiseasesGastrointestinal DiseasesDigestive System DiseasesHernia

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

February 2, 2024

First Posted

February 12, 2024

Study Start

March 1, 2024

Primary Completion

September 1, 2025

Study Completion

October 1, 2025

Last Updated

January 29, 2026

Record last verified: 2026-01

Data Sharing

IPD Sharing
Will not share

Locations